A 48-year-old woman from Mumbai with a 10-year history of type 2 diabetes mellitus presents with complaints of palpitations and tremor for the past 3 days. Vital signs: BP 178/96 mmHg, HR 118/min, RR 22/min. Physical examination reveals pallor, diaphoresis, and a palpable abdominal mass in the left upper quadrant. Plasma glucose is 312 mg/dL, and serum potassium is 3.1 mEq/L. A 24-hour urine metanephrine is markedly elevated at 850 μg (normal <400). CT abdomen shows a 4 cm left adrenal mass. Which of the following BEST describes the mechanism by which this patient's blood pressure elevation is maintained?

Explanation

## Pheochromocytoma: Catecholamine-Mediated Hypertension ### Clinical Diagnosis This patient has **pheochromocytoma** — a catecholamine-secreting tumor of the adrenal medulla. The clinical triad of **episodic headache, profuse sweating, and palpitations** combined with markedly elevated plasma metanephrines and an adrenal mass on imaging is pathognomonic. ### Mechanism of Hypertension in Pheochromocytoma **Key Point:** Pheochromocytoma causes hypertension primarily through **α₁-adrenergic receptor stimulation on vascular smooth muscle**, leading to sustained or episodic vasoconstriction. The catecholamine excess (epinephrine and norepinephrine) overwhelmingly activates α-receptors, which are more sensitive to catecholamines and cause potent vasoconstriction. ### Why Option 0 is Correct In pheochromocytoma: 1. **Massive catecholamine release** → predominantly norepinephrine (which has higher α₁-selectivity than epinephrine) 2. **α₁-adrenergic receptor activation** → sustained vasoconstriction of arterioles and resistance vessels 3. **Unopposed α-effects** → Because catecholamine levels are so high and sustained, the initial β-mediated vasodilation (seen at lower catecholamine concentrations) is overwhelmed by α₁-vasoconstriction 4. **Result:** Marked elevation in peripheral vascular resistance (PVR) and systolic/diastolic hypertension **High-Yield:** The **α-to-β ratio** determines the hemodynamic effect. In pheochromocytoma, the α-effects dominate because: - Norepinephrine (the predominant catecholamine in pheochromocytoma) has high α₁-selectivity and low β₂-activity - Epinephrine (which has more β-activity) is also released but in lower proportions - The sheer excess of catecholamines saturates α₁-receptors, causing unopposed vasoconstriction ### Hemodynamic Profile | Parameter | Pheochromocytoma | Normal Catecholamine Response | |-----------|------------------|------------------------------| | **Systolic BP** | ↑↑ (often >160) | Mild ↑ | | **Diastolic BP** | ↑↑ (often >90) | Mild ↑ | | **Heart Rate** | ↑ (reflex tachycardia) | ↑ | | **Cardiac Output** | Normal or ↓ (due to α-mediated afterload) | ↑ | | **Peripheral Vascular Resistance** | ↑↑↑ (dominant mechanism) | Mild ↑ | | **Plasma Volume** | Often ↓ (due to α-mediated vasoconstriction) | Normal | **Clinical Pearl:** Unlike essential hypertension or hyperaldosteronism, pheochromocytoma causes hypertension through **vasoconstriction**, not volume expansion. The patient's hypokalemia (K⁺ = 3.1) is due to catecholamine-induced shift of potassium intracellularly (via β₂-stimulation of Na⁺-K⁺-ATPase), not aldosterone excess. ### Why the Other Options Are Incorrect **Option 1 (β-adrenergic increase in cardiac output):** While β-adrenergic stimulation does increase heart rate and contractility in pheochromocytoma, the **dominant hemodynamic mechanism is α-mediated vasoconstriction**, not increased cardiac output. The elevated BP is primarily due to increased PVR, not increased CO. Additionally, the reflex bradycardia (baroreceptor reflex) often counteracts the direct β-tachycardic effect, so HR elevation is less consistent than BP elevation. **Option 2 (RAAS activation):** Although catecholamines can stimulate renin release through β₁-effects on juxtaglomerular cells, the **primary mechanism of hypertension in pheochromocytoma is direct α₁-mediated vasoconstriction**, not RAAS activation. RAAS plays a minor role and is not the BEST explanation. Additionally, the patient's hypokalemia argues against significant aldosterone excess (which would cause hypokalemia through a different mechanism — renal potassium wasting). **Option 3 (Osmotic hypertension from glucose):** Hyperglycemia can cause osmotic effects and mild volume expansion, but this does not explain the acute, severe hypertension in pheochromocytoma. The patient's hypertension is catecholamine-driven, not glucose-driven. Osmotic hypertension is a mechanism in uncontrolled diabetes, not in pheochromocytoma. ### Mnemonic: **"5 P's of Pheochromocytoma"** - **P**ressure (hypertension — α-mediated) - **P**ain (headache — from hypertensive crisis) - **P**erspiration (diaphoresis — from catecholamine excess) - **P**alpitations (tachycardia — from β-stimulation and anxiety) - **P**allor (vasoconstriction → reduced skin perfusion) ### Diagnostic Confirmation **Key Point:** The diagnosis is confirmed by: 1. **Elevated 24-hour urine metanephrines** (>400 μg/24 hr) — this patient's value of 850 is markedly elevated 2. **Plasma free metanephrines** (>4× upper limit of normal) 3. **Imaging:** CT or MRI showing adrenal mass; MIBG scintigraphy for functional confirmation 4. **Genetic testing:** Consider if <40 years old or family history (MEN2, NF1, SDH mutations)